SAN DIEGO Echo, the company who created the first-ever hybrid microscope, announced today the completion of $7.5 million in Series A funding. The capital investment, co-led by Dolby Family Ventures and Tech Coast Angels (TCA), will support Echo in scaling manufacturing, strengthening the company’s sales infrastructure, and developing future technologies. Echo, formerly Echo Laboratories, is […]

FREMONT, CA— Early detection and diagnosis can greatly increase the chances of successful treatment of diseases. Flow cytometry puts time on the side of researchers and clinicians by giving them the ability to quickly analyze multiple characteristics of single cells simultaneously. Life science researchers know this, yet adoption of this technology has lagged. Cytek Biosciences […]

SAN FRANCISCO — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it raised an additional $33 million. To date, Twist Bioscience has raised a total of $166 million. “It is an exciting time to be leading Twist Bioscience as we expand our reach and continue to deliver industry-leading gene […]

Share loan from Dr. Heikki Lanckriet guarantees government soft loans Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that Dr. Heikki Lanckriet, Co-CEO and CSO of SYGNIS, will guarantee soft loans from the Spanish government with 500,000 of his SYGNIS shares. The guarantee secures the EUR 1.9 […]

Merck, a leading science and technology company, announced today the new startups participating in its Accelerator programs in Darmstadt, Germany and Nairobi, Kenya. The two program locations accept startups from different fields within Merck’s core specialisms: Darmstadt takes startups from the fields of healthcare, life sciences and performance materials, while Nairobi works exclusively on innovations […]

BOSTON 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced it has closed $20 million in a growth equity funding round. 908 Devices plans to use this infusion of capital to accelerate penetration into already established markets for its purpose-built devices that range from rugged, handheld chemical detection tools to […]

Financing to Drive Commercialization of Next Generation Biotechnology Instrumentation for Drug Discovery and Development BURLINGTON, MA RedShift BioAnalytics, Inc., an innovative provider of bioanalytical instrumentation for the research, development and manufacturing of protein therapeutic drugs, today announced the closing of the Company’s $11.0 million Series C Preferred Stock financing. The financing was co-led by Waters […]